The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of disease-free survival in CheckMate 274 by PD-L1 combined positive score and tumor proportion score.
 
Matt D. Galsky
Stock and Other Ownership Interests - Rappta Therapeutics
Consulting or Advisory Role - Aileron Therapeutics; Astellas Pharma; AstraZeneca; Basilea; BioMotiv; Bristol-Myers Squibb; Dendreon; Dracen; Dragonfly Therapeutics; EMD Serono; Genentech; Gilead Sciences; GlaxoSmithKline; Incyte; Infinity Pharmaceuticals; Inovio Pharmaceuticals; Janssen; Lilly; Merck; Novartis; NuMab; Pfizer; Seagen; Urogen pharma
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792
 
Dean F. Bajorin
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Dragonfly Therapeutics; Fidia Farmaceutici S. p. A.; Merck
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Seattle Genetics/Astellas (Inst)
Travel, Accommodations, Expenses - Merck
 
J. Alfred Witjes
Honoraria - Astellas Pharma; AstraZeneca; Beigene; Bristol-Myers Squibb/Pfizer; Ferring; Janssen; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD; Nucleix; Oncodiag; Sanofi/Aventis
 
Jürgen E. Gschwend
Honoraria - Bayer Schering Pharma; Bristol-Myers Squibb; Janssen-Cilag
Consulting or Advisory Role - Bayer Schering Pharma; Bristol-Myers Squibb; Janssen-Cilag
 
Yoshihiko Tomita
Honoraria - Astellas Amgen BioPharama; Bristol-Myers Squibb; Ono Pharmaceutical; Pfizer
Research Funding - Ono Pharmaceutical (Inst); Takeda (Inst)
 
Federico Nasroulah
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Jun Li
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Sandra Collette
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Begoña Pérez-Valderrama
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Novartis; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; MSD Oncology; Novartis; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Ipsen; MSD Oncology; Pfizer; Roche
 
Marc-Oliver Grimm
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Merck Serono; MSD; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck Serono; MSD; Pfizer; Roche Pharma AG; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Intuitive Surgical (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono
 
Leonard Joseph Appleman
Consulting or Advisory Role - AADi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AVEO (Inst); Bayer (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Eisai (Inst); Epizyme (Inst); Exelixis (Inst); Genentech/Roche (Inst); Inovio Pharmaceuticals (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Surface Oncology (Inst)
Other Relationship - Pfizer
(OPTIONAL) Uncompensated Relationships - Exelixis
 
Gwenaelle Gravis
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); IPSEN (Inst); Janssen (Inst); MSD Oncology (Inst); Pfizer (Inst); Sanofi/Aventis (Inst)
Speakers' Bureau - Amgen (Inst); Astellas Pharma (Inst); BMS (Inst); Ipsen (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Sanofi/Aventis (Inst)
Research Funding - BMS (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Pfizer; Sanofi
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Honoraria - AstraZeneca; Bristol-Myers Squibb; Foundation Medicine; Janssen; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Ferring; GlaxoSmithKline; Incyte; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche; Seattle Genetics/Astellas
Research Funding - AstraZeneca (Inst); Ipsen; Merck Sharp & Dohme (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche
Other Relationship - Bayer (I)
 
Dingwei Ye
No Relationships to Disclose
 
Frank Stenner
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Roche; Sanofi
Research Funding - Bristol-Myers Squibb Foundation/Janssen
Patents, Royalties, Other Intellectual Property - ccH; CCH (I); Cureab; Cureab (I); GmBH; GMBH (I)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Sanofi
 
Megan Wind-Rotolo
Employment - Agios; Bristol-Myers Squibb
Stock and Other Ownership Interests - Agios; Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - PCT patent publication WO2020/198676 (Inst)
Other Relationship - Huntsworth Health (I)
 
Joshua Zhang
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Keziban Unsal-Kacmaz
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb